a year ago
MDGL
AnalystsLiisa BaykoLiisa Bayko's Stock Forecasts
AnalystsLiisa Bayko
Sectors:
Industries:
Analyst Ranking
Top 9%
#408 out of 4867 analysts
Average Return
+17.43%
Win Rate
52%33 out of 63
Risk vs Reward
Poor
Good
Liisa Bayko's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Madrigal Pharmaceuticals IncMDGL | +400.61% | $57.58 | $288.25 | 2022-01-31 - 2023-01-31 | Buy |
Madrigal Pharmaceuticals IncMDGL | +353.37% | $64.44 | $292.15 | 2022-05-10 - 2023-05-10 | Buy |
Enanta Pharmaceuticals IncENTA | +233.35% | $36.19 | $120.64 | 2017-07-11 - 2018-07-11 | Buy |
Madrigal Pharmaceuticals IncMDGL | +212.89% | $79.90 | $250.00 | 2021-12-20 - 2022-12-20 | Buy |
Biocryst Pharmaceuticals IncBCRX | +165.45% | $4.66 | $12.37 | 2020-11-24 - 2021-11-23 | Buy |
Liisa Bayko Analyst Color
Get additional color on Liisa Bayko's coverage of popular stocks
Liisa Bayko's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crispr Therapeutics AgCRSP | 2 | Buy | $99.00 | +153.13% | Upgrades | 2 months ago |
Travere Therapeutics IncTVTX | 5 | Buy | $45.00 | +155.25% | Maintains | 2 months ago |
Biocryst Pharmaceuticals IncBCRX | 5 | Buy | $12.00 | +45.99% | Maintains | 3 months ago |
Editas Medicine IncEDIT | 4 | Buy | $5.00 | +210.56% | Maintains | 4 months ago |
Carisma Therapeutics IncCARM | 2 | Hold | $0.70 | +225.58% | Downgrades | 4 months ago |
Savara IncSVRA | 2 | Hold | $5.00 | +52.91% | Downgrades | 5 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 3 | Buy | $35.00 | +70.23% | Maintains | 6 months ago |
Madrigal Pharmaceuticals IncMDGL | 9 | Buy | $360.00 | +12.52% | Maintains | 9 months ago |
Alnylam Pharmaceuticals IncALNY | 1 | Buy | $260.00 | +7.17% | Maintains | 10 months ago |
Aerovate Therapeutics IncAVTE | 2 | Hold | $2.00 | -26.47% | Downgrades | 10 months ago |
An2 Therapeutics IncANTX | 2 | Hold | $2.00 | +55.04% | Maintains | a year ago |
89bio IncETNB | 4 | Buy | $33.00 | +378.26% | Maintains | a year ago |
Akero Therapeutics IncAKRO | 3 | Buy | $38.00 | -7.29% | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 13 | Buy | $438.00 | N/A | Upgrades | a year ago |
Ultragenyx Pharmaceutical IncRARE | 5 | Buy | $80.00 | N/A | Upgrades | 2 years ago |
Astria Therapeutics IncATXS | 1 | Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Altimmune IncALT | 1 | Buy | $25.00 | N/A | Maintains | 2 years ago |
Enanta Pharmaceuticals IncENTA | 4 | Buy | $62.00 | N/A | Upgrades | 3 years ago |
Aura Biosciences IncAURA | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Vera Therapeutics IncVERA | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Translate Bio IncTBIO1 | 1 | Hold | $378.00 | N/A | Downgrades | 4 years ago |
Theravance Biopharma IncTBPH | 1 | Buy | $30.00 | N/A | Reinstates | 4 years ago |
Aimmune Therapeutics IncAIMT | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Arbutus Biopharma CorpABUS | 1 | Buy | $10.00 | N/A | Upgrades | 5 years ago |
Intercept Pharmaceuticals IncICPT | 2 | Buy | $175.00 | N/A | Upgrades | 6 years ago |
Strongbridge Biopharma PLCSBBP | 1 | Buy | $16.00 | N/A | Maintains | 7 years ago |
Ocera Therapeutics IncOCRX | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.